Exact Sciences posted $102.9 million in second quarter 2018 revenue, missing investor predictions by $1.8 million, or 1.7 percent, causing its stock to fall 18.75 percent.
Exact Sciences is sponsoring Fight Colorectal Cancer and PGA Tour professional Tom Lehman to promote Fight CRC.
RedHill Biopharma’s Crohn’s disease drug, RHB-104, successfully met its primary and secondary endpoints, achieving remission at 26 weeks.
More articles on gastroenterology:
Actor Matthew Perry undergoes tracheostomy in Los Angeles hospital — 5 insights
ASGE recognizes Metropolitan Gastroenterology Consultants — 3 insights
Dr. William Karnes: Key trends and challenges in GI today
